Free Trial

Randall K. Fields Sells 2,626 Shares of ReposiTrak Inc. (NYSE:TRAK) Stock

ReposiTrak logo with Computer and Technology background

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,626 shares of ReposiTrak stock in a transaction that occurred on Monday, June 30th. The shares were sold at an average price of $20.01, for a total transaction of $52,546.26. Following the sale, the chief executive officer owned 159,374 shares of the company's stock, valued at approximately $3,189,073.74. The trade was a 1.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

ReposiTrak Stock Performance

Shares of NYSE TRAK remained flat at $19.35 during trading on Wednesday. The company's stock had a trading volume of 44,361 shares, compared to its average volume of 59,467. The stock has a market cap of $353.72 million, a price-to-earnings ratio of 56.91 and a beta of 0.51. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03. ReposiTrak Inc. has a twelve month low of $15.72 and a twelve month high of $25.01.

ReposiTrak Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Shareholders of record on Monday, June 30th will be issued a $0.0182 dividend. This represents a $0.07 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Monday, June 30th. ReposiTrak's payout ratio is presently 20.59%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Check Out Our Latest Stock Report on TRAK

Institutional Investors Weigh In On ReposiTrak

An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC increased its position in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,289 shares of the company's stock after buying an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 as of its most recent filing with the SEC. 27.35% of the stock is currently owned by institutional investors.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Read More

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines